PMID- 23817305 OWN - NLM STAT- MEDLINE DCOM- 20131112 LR - 20140628 IS - 1423-0097 (Electronic) IS - 1018-2438 (Linking) VI - 162 IP - 1 DP - 2013 TI - Anisakis allergy component-resolved diagnosis: clinical and immunologic differences between patients from Italy and Spain. PG - 39-44 LID - 10.1159/000351056 [doi] AB - BACKGROUND: Anisakissimplex is the main organism responsible for the zoonotic disease anisakiasis which follows the ingestion of live larvae present in raw or undercooked marine fish. Clinical features include severe epigastric pain, frequently accompanied by severe allergic reactions. We investigated the prevalence of immunoglobulin E (IgE) specific for 5 Anisakis allergens in Italian patients sensitized or allergic to the parasite. The results were compared with those obtained previously in a similar Spanish population. PATIENTS AND METHODS: We conducted a descriptive, cross-sectional validation study. Asymptomatic Anisakis-sensitized subjects (15 Italian and 17 Spanish) and Anisakis allergic-patients (42 Italian and 35 Spanish) were studied by ImmunoCAP, Western-blotting with nAni s 4 and dot-blotting with rAni s 1, rAni s 5, rAni s 9 and rAni s 10. RESULTS: Anisakis IgE CAP classes 1 or 2 were associated with a high probability of asymptomatic sensitization (66.7%) while CAP classes 4 or above, were associated with a very high probability of allergy to Anisakis (95.2%). The most frequently detected allergen among Italian and Spanish allergic patients was Ani s 1. All of the Spanish patients versus 76.2% of the Italian patients recognized at least one of the allergens tested. Patients suffering from gastrointestinal symptoms only were significantly more frequent among the Italians whereas the Spanish presented more frequently with urticaria, angioedema or anaphylaxis. CONCLUSIONS: Anisakis hypersensitivity shows different immunological patterns in different European countries. Allergen component diagnosis might help us to better understand this complex entity. Anisakis-specific IgE levels may have moderate prognostic significance. CI - Copyright (c) 2013 S. Karger AG, Basel. FAU - Caballero, Maria Luisa AU - Caballero ML AD - Department of Immunology, Hospital Carlos III, Madrid, Spain. FAU - Asero, Riccardo AU - Asero R FAU - Antonicelli, Leonardo AU - Antonicelli L FAU - Kamberi, Erilda AU - Kamberi E FAU - Colangelo, Caterina AU - Colangelo C FAU - Fazii, Paolo AU - Fazii P FAU - de Burgos, Carmen AU - de Burgos C FAU - Rodriguez-Perez, Rosa AU - Rodriguez-Perez R LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130626 PL - Switzerland TA - Int Arch Allergy Immunol JT - International archives of allergy and immunology JID - 9211652 RN - 0 (Allergens) RN - 0 (Antigens, Helminth) RN - 0 (Calcium-Binding Proteins) RN - 0 (Helminth Proteins) RN - 0 (troponin-like protein, Anisakis simplex) RN - 37341-29-0 (Immunoglobulin E) SB - IM CIN - Int Arch Allergy Immunol. 2014;163(4):243-4. PMID: 24603096 MH - Allergens/*immunology MH - Animals MH - Anisakis/*immunology MH - Antigens, Helminth/immunology MH - Blotting, Western MH - Calcium-Binding Proteins/immunology MH - Cross-Sectional Studies MH - Food Hypersensitivity/immunology MH - Helminth Proteins/immunology MH - Humans MH - Hypersensitivity/immunology MH - Immunoblotting MH - Immunoglobulin E/immunology MH - Italy MH - Spain EDAT- 2013/07/03 06:00 MHDA- 2013/11/13 06:00 CRDT- 2013/07/03 06:00 PHST- 2013/01/11 00:00 [received] PHST- 2013/03/27 00:00 [accepted] PHST- 2013/07/03 06:00 [entrez] PHST- 2013/07/03 06:00 [pubmed] PHST- 2013/11/13 06:00 [medline] AID - 000351056 [pii] AID - 10.1159/000351056 [doi] PST - ppublish SO - Int Arch Allergy Immunol. 2013;162(1):39-44. doi: 10.1159/000351056. Epub 2013 Jun 26.